Please Wait.....

Report

Europe Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Market Report I 2023-09-01 I 205 Pages I Data Bridge Market Research

The Europe colorectal cancer diagnostics market is expected to reach USD 1,765.81 million by 2030 from USD 975.02 million in 2022, growing at a CAGR of 7.7% in the forecast period of 2023 to 2030.
Market Segmentation
Europe Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy and Others), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe) - Industry Trends and Forecast to 2030

Overview of Europe Colorectal Cancer Diagnostics Market Dynamics

Driver
- Growing prevalence of colorectal cancer

Restraint

- Stringent regulatory policies

Opportunity

- Rise in healthcare expenditure for cancer diagnosis and treatment

Market Players

Some of the key market players operating in the Europe colorectal cancer diagnostics market are
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Abbott
- Siemens Healthcare GmbH
- Merck KGAA
- Hologic, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Quest Diagnostics Incorporated.
- Bio-Rad Laboratories, Inc.
- Koninklijke Philips N.V.
- BD
- Time Medical Holding
- PlexBio
- Neusoft Corporation
- BioFire Diagnostics
- MinFound Medical Systems Co., Ltd
- Medonica Co. LTD
- CANON MEDICAL SYSTEMS CORPORATION

TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF THE EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET 20
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 MULTIVARIATE MODELLING 31
2.7 PRODUCT TYPE LIFELINE CURVE 31
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.9 DBMR MARKET POSITION GRID 33
2.10 MARKET END USER COVERAGE GRID 34
2.11 VENDOR SHARE ANALYSIS 35
2.12 SECONDARY SOURCES 36
2.13 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 40
4.1 PORTER'S FIVE FORCES 42
4.2 PESTEL ANALYSIS 43
5 INDUSTRY INSIGHTS: 44
6 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 45
6.1 REGULATORY SCENARIO IN THE GERMANY 45
6.2 REGULATORY SCENARIO IN FRANCE 45
6.3 REGULATORY SCENARIO IN RUSSIA 46
6.4 REGULATORY SCENARIO IN ITALY 46?
7 MARKET OVERVIEW 47
7.1 DRIVERS 49
7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 49
7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 49
7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 49
7.2 RESTRAINTS 50
7.2.1 STRINGENT REGULATORY POLICIES 50
7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 51
7.3 OPPORTUNITIES 51
7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 51
7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 52
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 53
7.4 CHALLENGES 53
7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 53
7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 54
8 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 55
8.1 OVERVIEW 56
8.2 INSTRUMENTS 58
8.2.1 PATHOLOGY-BASED INSTRUMENTS 59
8.2.1.1 PCR INSTRUMENTS 60
8.2.1.2 SLIDE STAINING SYSTEMS 60
8.2.1.3 TISSUE PROCESSING SYSTEMS 60
8.2.1.4 CELL PROCESSORS 60
8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 60
8.2.2 IMAGING INSTRUMENTS 61
8.2.2.1 ULTRASOUND SYSTEMS 61
8.2.2.2 CT SYSTEMS 61
8.2.2.3 MRI SYSTEMS 61
8.2.2.4 OTHERS 61
8.2.3 BIOPSY INSTRUMENTS 61
8.2.4 OTHERS 62
8.3 CONSUMABLES & ACCESSORIES 62
8.3.1 KITS 63
8.3.1.1 PCR KITS 63
8.3.1.2 DNA POLYMERASE KITS 63
8.3.1.3 NUCLEIC ACID ISOLATION KITS 63
8.3.1.4 OTHERS 63?
8.3.2 REAGENTS 64
8.3.2.1 ASSAYS 64
8.3.2.2 BUFFERS 64
8.3.2.3 PRIMERS 64
8.3.2.4 OTHERS 64
8.3.3 OTHER CONSUMABLES 64
9 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 65
9.1 OVERVIEW 66
9.2 STOOL EXAMINATION 68
9.3 BLOOD TEST 69
9.3.1 COMPLETE BLOOD COUNT (CBC) 70
9.3.2 TUMOR MARKER TEST 70
9.3.3 LIVER ENZYME BLOOD TEST 70
9.4 IMAGING TEST 70
9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 71
9.4.2 MRI 71
9.4.3 ULTRASOUND 71
9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 71
9.4.5 OTHERS 71
9.5 TUMOR MARKERS 72
9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 72
9.5.2 CA19-9 BIOMARKER TEST 72
9.5.3 CA 50 MARKER TEST 73
9.5.4 OTHERS 73
9.6 BIOPSY 73
9.7 OTHERS 73
10 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 74
10.1 OVERVIEW 75
10.2 STAGE III 77
10.3 STAGE IV 78
10.4 STAGE II 78
10.5 STAGE I 79
10.6 STAGE 0 79
11 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 80
11.1 OVERVIEW 81
11.2 GERIATRIC 83
11.3 ADULTS 84
11.4 PEDIATRIC 84
12 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 85
12.1 OVERVIEW 86
12.2 ADENOCARCINOMA 88
12.3 COLORECTAL LYMPHOMA 89
12.4 GASTROINTESTINAL STROMAL TUMORS 89
12.5 CARCINOID TUMORS 90
12.6 OTHERS 90
13 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 91
13.1 OVERVIEW 92
13.2 HOSPITALS 95
13.3 DIAGNOSTIC CENTERS 95
13.4 CANCER RESEARCH CENTERS 95
13.5 AMBULATORY SURGICAL CENTERS 96
13.6 ACADEMIC INSTITUTES 96
13.7 OTHERS 96
14 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY 98
14.1 EUROPE 98
14.1.1 GERMANY 103
14.1.2 FRANCE 108
14.1.3 U.K. 113
14.1.4 ITALY 118
14.1.5 SPAIN 123
14.1.6 RUSSIA 128
14.1.7 TURKEY 133
14.1.8 NETHERLANDS 138
14.1.9 BELGIUM 143
14.1.10 SWITZERLAND 148
14.1.11 REST OF EUROPE 153
15 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 154
15.1 COMPANY SHARE ANALYSIS: EUROPE 154
16 SWOT ANALYSIS 155
17 COMPANY PROFILES 156
17.1 F. HOFFMANN- LA ROCHE LTD 156
17.1.1 COMPANY SNAPSHOT 156
17.1.2 REVENUE ANALYSIS 156
17.1.3 PRODUCT PORTFOLIO 157
17.1.4 RECENT DEVELOPMENT 157
17.2 KONINKLIJKE PHILIPS N.V. 158
17.2.1 COMPANY SNAPSHOT 158
17.2.2 REVENUE ANALYSIS 158
17.2.3 PRODUCT PORTFOLIO 159
17.2.4 RECENT DEVELOPMENT 159
17.3 THERMO FISHER SCIENTIFIC INC. 160
17.3.1 COMPANY SNAPSHOT 160
17.3.2 REVENUE ANALYSIS 160
17.3.3 PRODUCT PORTFOLIO 160
17.3.4 RECENT DEVELOPMENT 161
17.4 ILLUMINA, INC. 162
17.4.1 COMPANY SNAPSHOT 162
17.4.2 REVENUE ANALYSIS 162
17.4.3 PRODUCT PORTFOLIO 163
17.4.4 RECENT DEVELOPMENT 163
17.5 QUEST DIAGNOSTICS INCORPORATED 164
17.5.1 COMPANY SNAPSHOT 164
17.5.2 REVENUE ANALYSIS 164
17.5.3 PRODUCT PORTFOLIO 165
17.5.4 RECENT DEVELOPMENT 165
17.6 ABBOTT 166
17.6.1 COMPANY SNAPSHOT 166
17.6.2 REVENUE ANALYSIS 166
17.6.3 PRODUCT PORTFOLIO 167
17.6.4 RECENT DEVELOPMENT 167
17.7 AGILENT TECHNOLOGIES, INC. 168
17.7.1 COMPANY SNAPSHOT 168
17.7.2 REVENUE ANALYSIS 168
17.7.3 PRODUCT PORTFOLIO 169
17.7.4 RECENT DEVELOPMENT 169
17.8 BD 170
17.8.1 COMPANY SNAPSHOT 170
17.8.2 REVENUE ANALYSIS 170
17.8.3 PRODUCT PORTFOLIO 171
17.8.4 RECENT DEVELOPMENT 171
17.9 BIOFIRE DIAGNOSTICS 172
17.9.1 COMPANY SNAPSHOT 172
17.9.2 REVENUE ANALYSIS 172
17.9.3 PRODUCT PORTFOLIO 173
17.9.4 RECENT DEVELOPMENT 173
17.10 BIO-RAD LABORATORIES, INC. 174
17.10.1 COMPANY SNAPSHOT 174
17.10.2 REVENUE ANALYSIS 174
17.10.3 PRODUCT PORTFOLIO 175
17.10.4 RECENT DEVELOPMENT 175
17.11 CANON MEDICAL SYSTEMS CORPORATION. 176
17.11.1 COMPANY SNAPSHOT 176
17.11.2 REVENUE ANALYSIS 176
17.11.3 PRODUCT PORTFOLIO 177
17.11.4 RECENT DEVELOPMENT 177
17.12 FONAR CORP. 178
17.12.1 COMPANY SNAPSHOT 178
17.12.2 REVENUE ANALYSIS 178
17.12.3 PRODUCT PORTFOLIO 179
17.12.4 RECENT DEVELOPMENT 179
17.13 FUJIFILM CORPORATION 180
17.13.1 COMPANY SNAPSHOT 180
17.13.2 REVENUE ANALYSIS 180
17.13.3 PRODUCT PORTFOLIO 181
17.13.4 RECENT DEVELOPMENT 181
17.14 GE HEALTHCARE. 182
17.14.1 COMPANY SNAPSHOT 182
17.14.2 REVENUE ANALYSIS 182
17.14.3 PRODUCT PORTFOLIO 183
17.14.4 RECENT DEVELOPMENT 183
17.15 HOLOGIC, INC. 184
17.15.1 COMPANY SNAPSHOT 184
17.15.2 REVENUE ANALYSIS 184
17.15.3 PRODUCT PORTFOLIO 184
17.15.4 RECENT DEVELOPMENT 185
17.16 MEDONICA CO. LTD 186
17.16.1 COMPANY SNAPSHOT 186
17.16.2 PRODUCT PORTFOLIO 186
17.16.3 RECENT DEVELOPMENT 186
17.17 MERCK KGAA 187
17.17.1 COMPANY SNAPSHOT 187
17.17.2 REVENUE ANALYSIS 187
17.17.3 PRODUCT PORTFOLIO 187
17.17.4 RECENT DEVELOPMENT 188

17.18 MINFOUND MEDICAL SYSTEMS CO., LTD 189
17.18.1 COMPANY SNAPSHOT 189
17.18.2 PRODUCT PORTFOLIO 189
17.18.3 RECENT DEVELOPMENT 190
17.19 MYRIAD GENETICS, INC. 191
17.19.1 COMPANY SNAPSHOT 191
17.19.2 REVENUE ANALYSIS 191
17.19.3 PRODUCT PORTFOLIO 192
17.19.4 RECENT DEVELOPMENT 192
17.20 NEUSOFT CORPORATION 193
17.20.1 COMPANY SNAPSHOT 193
17.20.2 REVENUE ANALYSIS 193
17.20.3 PRODUCT PORTFOLIO 194
17.20.4 RECENT DEVELOPMENT 194
17.21 PLEXBIO 195
17.21.1 COMPANY SNAPSHOT 195
17.21.2 PRODUCT PORTFOLIO 195
17.21.3 RECENT DEVELOPMENT 195
17.22 QIAGEN 196
17.22.1 COMPANY SNAPSHOT 196
17.22.2 REVENUE ANALYSIS 196
17.22.3 PRODUCT PORTFOLIO 197
17.22.4 RECENT DEVELOPMENT 197
17.23 SIEMENS HEALTHCARE GMBH 198
17.23.1 COMPANY SNAPSHOT 198
17.23.2 REVENUE ANALYSIS 198
17.23.3 PRODUCT PORTFOLIO 199
17.23.4 RECENT DEVELOPMENT 199
17.24 STERNMED GMBH 200
17.24.1 COMPANY SNAPSHOT 200
17.24.2 PRODUCT PORTFOLIO 200
17.24.3 RECENT DEVELOPMENT 200
18 QUESTIONNAIRE 201
19 RELATED REPORTS 205

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.